Literature DB >> 24990114

Migraine and obesity: metabolic parameters and response to a weight loss programme.

A Verrotti1, M Carotenuto, L Altieri, P Parisi, E Tozzi, V Belcastro, M Esposito, N Guastaferro, A Ciuti, A Mohn, F Chiarelli, S Agostinelli.   

Abstract

BACKGROUND AND
OBJECTIVE: Weight loss can determine significant improvement of migraine in obese patients. Herein, we evaluated a clinical sample of adolescent migraineurs with obesity who participated in an interdisciplinary programme for weight loss, in order to identify possible metabolic parameters associated with good migraine control. SUBJECTS AND METHODS: Using a cross-sectional design, we evaluated 112 out of 135 adolescents who previously underwent our intervention programme. Based on persistence of headache, subjects for comparison were 40 migraine-free and 72 not migraine-free adolescents. Participants underwent anthropometric evaluations and biochemical tests.
RESULTS: Patients with persistence of migraine had significantly higher weight (P < 0.01), body mass index (P < 0.01), waist circumference (P < 0.01), homeostasis model assessment of insulin resistance (P < 0.001), triglyceride (P < 0.05), total cholesterol (P < 0.05) and low-density lipoprotein cholesterol (P < 0.05) values when compared with those who became migraine-free. Between potential predictors, only insulin resistance (odds ratio = 3.5, 95% confidence interval = 1.4-6.1; P <  0.001) was significantly associated with persistence of migraine after intervention programme.
CONCLUSIONS: Among obese adolescents with migraine who underwent an intervention programme for weight loss, patients who did not become migraine-free showed higher adiposity values than those who became migraine-free. Patients with insulin resistance had 3.5 times the odds of having persistence of migraine compared with those without.
© 2014 The Authors. Pediatric Obesity © 2014 World Obesity.

Entities:  

Keywords:  insulin resistance; migraine; obesity; weight loss

Mesh:

Substances:

Year:  2014        PMID: 24990114     DOI: 10.1111/ijpo.245

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   4.000


  18 in total

1.  Fasting lipid and lipoproteins concentrations in pregnant women with a history of migraine.

Authors:  Bizu Gelaye; Gloria T Larrabure-Torrealva; Chunfang Qiu; Miguel Angel Luque-Fernandez; B Lee Peterlin; Sixto E Sanchez; Michelle A Williams
Journal:  Headache       Date:  2015-04-22       Impact factor: 5.887

Review 2.  A Clinical Approach to Addressing Diet with Migraine Patients.

Authors:  Margaret Slavin; Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

3.  The Effect of Bariatric Surgery on Migraines: a Systematic Review and Meta-analysis.

Authors:  Jerry T Dang; Jeremy K H Lee; Janice Y Kung; Noah J Switzer; Shahzeer Karmali; Daniel W Birch
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

Review 4.  Migraine, Cyclic Vomiting Syndrome, and Other Gastrointestinal Disorders.

Authors:  Elliot S Yu; Yasodara Priyadharsini S S; Thangam Venkatesan
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 5.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

6.  Forehead carbuncle with intractable headache.

Authors:  Ping-Yin Chou; Yin-Chun Chen; Poyin Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-20       Impact factor: 2.570

7.  The importance of community consultation and social support in adhering to an obesity reduction program: results from the Healthy Weights Initiative.

Authors:  Mark Lemstra; Marla R Rogers
Journal:  Patient Prefer Adherence       Date:  2015-10-15       Impact factor: 2.711

Review 8.  Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.

Authors:  S Barja-Fernandez; R Leis; F F Casanueva; L M Seoane
Journal:  Drug Des Devel Ther       Date:  2014-12-01       Impact factor: 4.162

Review 9.  Gastrointestinal disorders associated with migraine: A comprehensive review.

Authors:  Carlos R Cámara-Lemarroy; Rene Rodriguez-Gutierrez; Roberto Monreal-Robles; Alejandro Marfil-Rivera
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

Review 10.  Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.

Authors:  Gianni Allais; Chiara Benedetto
Journal:  Drug Des Devel Ther       Date:  2016-10-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.